Skip to content
Posttest - Tumor Board Tuesday - January 11, 2022 (ID: i788-24)
*
1.
Please list your first name, last name, and email:
(Required.)
First name:
Last name:
Email:
*
2.
What is your specialty?
(Required.)
*
3.
Testing for ctDNA is commercially available for patients who have undergone resection of a colorectal cancer
(Required.)
True
False
*
4.
A 64 year old male with no comorbidities has undergone resection of a colorectal cancer. Pathology revealed a pT3, pN1b (3/24 LNs) moderately differentiated adenocarcinoma. Post-operative ctDNA was undetectable.
The guideline-recommended next approach for this patient is:
(Required.)
No adjuvant chemo
Adjuvant capecitabine
3 months of adjuvant CAPEOX
3 months of adjuvant FOLFOX